Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice

Journal of Clinical Investigation

Volumn 100, Issue 6, 1997, Pages 1344-1348

  Karounos, D G ^a,b   Bryson, J S ^a   Cohen, D A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Immunotherapy; Synthetic hormones; Type I diabetes mellitus

Indexed keywords

AMINO ACID; GLUCOSE; INSULIN; INSULIN DERIVATIVE; INSULIN RECEPTOR; ISOPHANE INSULIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOTHERAPY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030754787     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119654     Document Type: Article

References (25)

1. Serreze, D.V., and E.H. Leiter. 1994. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6:900-906.
2. Karounos, D.G., and J.W. Thomas. 1990. Recognition of a common islet cell antigen by autoantibodies from NOD mice and humans with IDDM. Diabetes. 39:1085-1090.
3. r islet antigen. Diabetes. 37:1587-1590.
4. Serreze, D.V., E.H. Leiter, E.L. Kuff, P. Jardieu, and K. Ishizaka. 1988. Molecular mimicry between insulin and retroviral antigen p73 development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice. Diabetes. 37:351-358.
5. Atkinson, M.A., N.K. Maclaren, and R. Luchetta. 1990. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes. 39:933-937.
6. Muir, A., J. Cornelius, V. Ramiya, J. Krischer, and A. Peck. 1994. Insulin B chain immunization activates regulatory T cells and reduces interferon-gamma (IFN-gamma) in NOD mouse islets. Diabetes. 43:94a.
7. Daniel, D., and D.R. Wegmann. 1996. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA. 93:956-960.
8. Hancock, W.W., M. Polanski, J. Zhang, N. Blogg, and H.L. Weiner. 1995. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am. J. Pathol. 147:1193-1199.
9. Hutchings, P.R., and A. Cooke. 1995. Comparative study of the protective effect afforded by intravenous administration of bovine or ovine insulin to young NOD mice. Diabetes. 44:906-910.
10. Karounos, D.G. 1995. Insulin immunotherapy delays onset of type I diabetes but does not reverse insulitis. J. Investig. Med. 43:324a.
11. Aaen, K., J. Rygaard, K. Josefsen, H. Petersen, C.H. Brogen, T. Horn, and K. Buschard. 1990. Dependence of antigen expression on functional state of β-cells. Diabetes. 39:697-701.
12. r islet cell autoantigen expression. Diabetes. 38:1326-1328.
13. Gladstone, P., and G.T. Nepom. 1995. The prevention of IDDM. Injecting insulin into the cytokine network. Diabetes. 44:859-862.
14. Peakman, M., M.J. Hussain, B.A. Millward, R.D.G. Leslie, and D. Vergani. 1990. Effect of initiation of insulin therapy on T-lymphocyte activation in type I diabetes. Diabetic Med. 7:327-330.
15. Helderman, J.H., A.O. Pietri, and P. Raskin. 1983. In vitro control of T-lymphocyte insulin receptors by in vivo modulation of insulin. Diabetes. 32: 712-717.
16. Volund, A., J. Brange, K. Drejer, I. Jensen, J. Markussen, U. Ribel, A.R. Sorensen, and J. Schlichtkrull. 1991. In vitro and in vivo potency of insulin analogues designed for clinical use. Diabetic Med. 8:839-847.
17. Drejer, K., V. Kruse, U.D. Larsen, P. Hougaard, S. Bjorn, and S. Gammeltoft. 1991. Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells. Diabetes. 40:1488-1495.
18. Serreze, D.V., E.H. Leiter, G.J. Christianson, D. Greiner, and D.C. Roopenian. 1994. Major histocompatibility complex class I deficient nodB2M(null) mice are diabetes and insulitis resistant. Diabetes. 43:505-509.
19. Brange, J., D.R. Owens, S. Kang, and A. Volund. 1990. Monomeric insulins and their experimental and clinical implications. Diabetes Care. 13:923-954.
20. Zhang, Z.J., L. Davidson, G. Eisenbarth, and H.L. Weiner. 1991. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA. 88:10252-10256.
21. Muir, A., A. Peck, M. Clare-Salzler, Y. Song, J. Cornelius, R. Luchetta, J. Krischer, and N. Maclaren. 1995. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J. Clin. Invest. 95:628-634.
22. Miller, G.G., M.S. Pollack, L.J. Nell, and J.W. Thomas. 1987. Insulin-specific human T cells: epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes-associated haplotype. J. Immunol. 139: 3622-3629.
23. Nell, L.J., and J.W. Thomas. 1983. The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics. J. Immunol. 131:701-705.
24. Wegmann, D.R., R.G. Gill, M. Norbury-Glaser, N. Schloot, and D. Daniel. 1994. Analysis of the spontaneous T cell response to insulin in NOD mice. J. Autoimmun. 7:833-843.
25. Daniel, D., R.G. Gill, N. Schloot, and D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056-1062.